The Wnt5a signaling pathway is involved in the progression of several cancers [1, 3–7]; Wnt5a contributes to the progression of gastric, lung, and prostate cancers [3–5], but serves as a tumor suppressor in thyroid and ovarian cancers [6, 7]. Here, WNT5A is linked to prostate carcinoma.